iRhythm Technologies UK Revenue and Competitors

Bagshot, UK

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • iRhythm Technologies UK's estimated annual revenue is currently $16.3M per year.(i)
  • iRhythm Technologies UK's estimated revenue per employee is $251,000

Employee Data

  • iRhythm Technologies UK has 65 Employees.(i)
  • iRhythm Technologies UK grew their employee count by 35% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$86.6M3452%N/AN/A
#2
$369.5M920-23%$974.7MN/A
#3
$1M40%N/AN/A
#4
$258.8M103118%N/AN/A
#5
$136M5428%N/AN/A
#6
$19.8M79-2%N/AN/A
#7
$51.7M2067%N/AN/A
#8
$40.9M16310%N/AN/A
#9
$85.1M3399%N/AN/A
#10
$40.4M1618%N/AN/A
Add Company

What Is iRhythm Technologies UK?

iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. Our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias. We have created a unique platform, ZIO by iRhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.

keywords:N/A

N/A

Total Funding

65

Number of Employees

$16.3M

Revenue (est)

35%

Employee Growth %

N/A

Valuation

N/A

Accelerator

iRhythm Technologies UK News

2022-04-20 - Best Research Report on Wearable Cardiac Devices Market ...

iRhythm Technologies Inc; Welch Allyn (Hillrom Services Inc.) VitalConnect ... Europe (U.K., Italy, Germany, France, Rest of EU)

2022-04-19 - Missed Intuitive Surgical? Buy This Stock Instead

Like Intuitive in its early days, iRhythm Technologies (NASDAQ: IRTC) is ... in select international markets, such as the U.K. and Japan.

2022-04-06 - AI device cuts waiting times for heart patients to 'matter of days'

iRhythm claims ambulatory cardiac monitoring technology is more than ... across the UK, to bring our Zio XT service to heart patients.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14M74N/AN/A
#2
$114.6M4046%N/A
#3
$75M1538N/AN/A